NCT00480441View on ClinicalTrials.gov

Effectiveness Study of Dronabinol and BRENDA for the Treatment of Cannabis Withdrawal

PHASE2CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

June 30, 2009

Study Completion Date

July 31, 2009

Conditions
Marijuana Dependence
Interventions
DRUG

Dronabinol

10mg capsules taken 4 times daily for 2 weeks and then tapered over 1 week

BEHAVIORAL

BRENDA therapy

weekly therapy sessions for 6 weeks

DRUG

Placebo

4 capsules daily for 2 weeks followed by a 1 week taper

Trial Locations (1)

19104

Treatment Research Center at the University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Pennsylvania

OTHER

NCT00480441 - Effectiveness Study of Dronabinol and BRENDA for the Treatment of Cannabis Withdrawal | Biotech Hunter | Biotech Hunter